500 patients67,039 observations150 daysLIVE

Patient P-03108

Synthetic patientONX-7 · Day 150 · 55–64 · M · baseline S19Open companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
23%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S19
  2. Day 96 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 96.

Primary contributors, last 14 days
  • Inflammatory activity+6
  • Treatment adherence-6
  • GI instability+3
  • Toxicity-3
  • Nutritional resilience-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients.

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Autonomic recovery 65
      • WearableResting HR 75 bpm
      • Wearable3,972 steps/day
      • WearableShort sleep window
    • Mucosal barrier integrity 60
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Inflammatory signalling 15
      • WearableHRV 35 ms, trending down
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Rapid metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4.3 · butyrate capacity 66/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumLow
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    31 ms
    Sleep
    6.7 h
    Steps
    3,750
    Resting HR
    73 bpm
    Daily log: GI score 18, nutritional resilience 69, adherence 74.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0312844%S0132
    P-0317343%S1739
    P-0338043%S16AD-05improved34
    P-0349443%S1838
    P-0309642%S0724
    P-0340242%S1630
    P-0334341%S1245
    P-0342441%S12AD-05improved41
    P-0319740%S1441
    P-0320240%S1444
    P-0323540%S13GI-04improved29
    P-0325040%S1244